{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T08:52:34Z","timestamp":1781686354216,"version":"3.54.5"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Retinal arteriosclerosis is a non-invasive indicator for systemic microvascular damage and early atherosclerosis. While traditional lipid measures are used to establish cardiovascular risk predictors, Apolipoprotein B (ApoB), Apolipoprotein A1 (ApoA1), and their ratio might provide more insights into the atherogenic burden. However, their association with retinal arteriosclerosis in general health populations has not yet been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included 4,938 adults from a health examination cohort. Retinal arteriosclerosis was evaluated by employing fundus photography and the SCHEIE classification. Multivariable logistic regression and restricted cubic spline analyses were used to evaluate the associations between apolipoproteins (ApoA1, ApoB\/ApoA1 ratio) and retinal arteriosclerosis, accounting for demographic, lifestyle, clinical, and laboratory confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In males, retinal arteriosclerosis prevalence was 13.98%, which is higher than females, who have 8.57%. People with retinal arteriosclerosis showed significantly higher ApoB levels and ApoB\/ApoA1 ratios. In fully adjusted models, both ApoB (per 1-SD increase: OR 1.12, 95% CI 1.01\u20131.24) and ApoB\/ApoA1 ratio (per 1-SD increase: OR 1.14, 95% CI 1.03\u20131.27) remained independently associated with retinal arteriosclerosis. Subgroup analyses revealed significant associations in adults \u226545 years, non-smokers, and non-hypertensive individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The ApoB\/ApoA1 ratio is independently linked to retinal arteriosclerosis, especially in older adults. These findings indicate that integrating apolipoprotein profiling into cardiovascular risk assessment could improve the early detection of microvascular damage by leveraging the \u201ceye-heart\u201d axis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1852420","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:55:40Z","timestamp":1781682940000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of the apolipoproteins with retinal arteriosclerosis in a health examination population"],"prefix":"10.3389","volume":"13","author":[{"given":"Xinghe","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Cardiology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lv","sequence":"additional","affiliation":[{"name":"Healthcare Management Center, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Wu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking University International Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/cvr\/cvab303","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. The road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0192350","DOI":"10.1371\/journal.pone.0192350","article-title":"Microvascular retinopathy and angiographically-demonstrated coronary artery disease: a cross-sectional, observational study","volume":"13","author":"Cheng","year":"2018","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1161\/CIRCULATIONAHA.116.023425","article-title":"Retinal vessel calibers in predicting long-term cardiovascular outcomes: the atherosclerosis risk in communities study","volume":"134","author":"Seidelmann","year":"2016","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1016\/S2589-7500(21)00043-1","article-title":"Deep-learning-based cardiovascular risk stratification using coronary artery calcium scores predicted from retinal photographs","volume":"3","author":"Rim","year":"2021","journal-title":"Lancet Digit Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s40001-023-01508-6","article-title":"Sex-specific association between carotid atherosclerosis and fundus arteriosclerosis in a Chinese population: a retrospective cross-sectional study","volume":"28","author":"Liu","year":"2023","journal-title":"Eur J Med Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"31931","DOI":"10.1038\/s41598-024-83467-4","article-title":"SS-OCTA assessment of fundus microvascular changes and their correlation with coronary lesion severity in severe coronary heart disease","volume":"14","author":"Zong","year":"2024","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 Risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Hageman","year":"2021","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-nutr-062222-020716","article-title":"Biosynthesis and metabolism of ApoB-containing lipoproteins","volume":"44","author":"Bor\u00e9n","year":"2024","journal-title":"Annu Rev Nutr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms25137048","article-title":"Apolipoproteins in health and disease","volume":"25","author":"Ord\u00f3\u00f1ez-Llanos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"13622","DOI":"10.1038\/s41598-025-97625-9","article-title":"Association of ApoB\/apoA1 ratio with stenosis of intracranial and extracranial arteries in patients with ischaemic stroke","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41598-024-84092-x","article-title":"Apob\/ApoA-\u0399 is associated with major cardiovascular events and readmission risk of patients after percutaneous coronary intervention in one year","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"key":"B18","first-page":"74","article-title":"Apob\/ApoA1 ratio and subclinical atherosclerosis","volume":"27","author":"Panayiotou","year":"2008","journal-title":"Int Angiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00392-018-1381-5","article-title":"Apolipoproteins A1, B, and apoB\/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up","volume":"108","author":"Bodde","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00392-025-02767-5","article-title":"Association of apolipoprotein B, excess apolipoprotein B and apoB\/apoA1 ratio with 20-year atherosclerotic cardiovascular disease risk: the ATTICA study (2002\u20132022)","volume":"115","author":"Giannakopoulou","year":"2025","journal-title":"Clin Res Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2012.10.049","article-title":"Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk","volume":"226","author":"Raitakari","year":"2013","journal-title":"Atherosclerosis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"118557","DOI":"10.1016\/j.atherosclerosis.2024.118557","article-title":"Development and validation of a risk prediction model for short-term progression of carotid atherosclerosis among early middle age adults","volume":"397","author":"Sun","year":"2024","journal-title":"Atherosclerosis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ophtha.2005.12.013","article-title":"Prevalence of age-related macular degeneration in 4 racial\/ethnic groups in the multi-ethnic study of atherosclerosis","volume":"113","author":"Klein","year":"2006","journal-title":"Ophthalmology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archopht.1953.00920020122001","article-title":"Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis","volume":"49","author":"Scheie","year":"1953","journal-title":"AMA Arch Ophthalmol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIRCRESAHA.119.315019","article-title":"Apob","volume":"124","author":"Sniderman","year":"2019","journal-title":"Circ Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/labinvest.2016.56","article-title":"Apoa1 and ApoA1-specific self-antibodies in cardiovascular disease","volume":"96","author":"Chistiakov","year":"2016","journal-title":"Lab Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","article-title":"Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A consensus statement from EAS and EFLM","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin Chem"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/2047487319899622","article-title":"Beyond LDL-C levels, does remnant cholesterol estimation matter?","volume":"27","author":"Pirillo","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/metabo11100690","article-title":"Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target","volume":"11","author":"Behbodikhah","year":"2021","journal-title":"Metabolites"},{"key":"B30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jacl.2011.02.001","article-title":"Clinical implications of discordance between low-density lipoprotein cholesterol and particle number","volume":"5","author":"Otvos","year":"2011","journal-title":"J Clin Lipidol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/MOL.0000000000000127","article-title":"Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB","volume":"25","author":"Sniderman","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e025858","DOI":"10.1161\/JAHA.122.025858","article-title":"Physiological bases for the superiority of apolipoprotein B over low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as a marker of cardiovascular risk","volume":"11","author":"Glavinovic","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.amjcard.2008.02.094","article-title":"Risk prediction of coronary heart disease based on retinal vascular caliber (from the atherosclerosis risk in communities [ARIC] study)","volume":"102","author":"McGeechan","year":"2008","journal-title":"Am J Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/HJH.0000000000002252","article-title":"Central arterial stiffness and retinal vessel calibers: the atherosclerosis risk in communities study-neurocognitive study","volume":"38","author":"Meyer","year":"2020","journal-title":"J Hypertens"},{"key":"B36","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00508-017-1235-6","article-title":"Moderate alcohol consumption and atherosclerosis: meta-analysis of effects on lipids and inflammation","volume":"129","author":"Huang","year":"2017","journal-title":"Wien Klin Wochenschr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"31646","DOI":"10.1038\/s41598-025-16290-0","article-title":"Association between alcohol consumption and carotid atherosclerosis in Russia","volume":"15","author":"Mitkin","year":"2025","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/add.15012","article-title":"Association between alcohol consumption and subclinical femoral atherosclerosis in smoking and non-smoking men: the AWHS study","volume":"115","author":"Moreno-Franco","year":"2020","journal-title":"Addiction"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (prediction for ASCVD risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1111\/dom.13372","article-title":"Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: a real-world observational analysis of a health claims database","volume":"20","author":"Kawasaki","year":"2018","journal-title":"Diabetes Obes Metab"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1852420\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:55:41Z","timestamp":1781682941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1852420\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":40,"alternative-id":["10.3389\/fcvm.2026.1852420"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1852420","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"article-number":"1852420"}}